Controversies in the Surgical Management of Pancreatic Cancer

  • Curtis J. Wray
  • Syed A. Ahmad
Part of the M. D. Anderson Solid Tumor Oncology Series book series (MDA)

Pancreatic ductal adenocarcinoma (PDA) remains the fourth most common cancer in the United States. The National Cancer Institute estimates 33,370 new cases of pancreatic cancer along with 32,300 deaths in the United States in 2006 (1, 2). The only hope for cure of PDA is surgical resection of localized disease. Over the past 20 years, significant advances in diagnostic imaging, staging, surgical technique, and perioperative care have led to a clear improvement in the surgical management of these patients (3). These advances have also led to decreased morbidity and mortality for patients following potentially curative surgery. Yet controversy remains for several aspects of the multimodality management and surgical care of patients diagnosed with PDA (4, 5). This chapter focuses on several topics that at this time remain controversial and are not universally accepted among pancreatic surgeons.


Pancreatic Cancer Pancreatic Fistula Pancreatic Ductal Adenocarcinoma Delay Gastric Emptying Preoperative Biliary Drainage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Petersen GM, Andrade M, de Goggins M. 2006, Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 15:704–710.CrossRefPubMedGoogle Scholar
  2. 2.
    Lowenfels AB, Maisonneuve P. 2006, Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20:197–209.CrossRefPubMedGoogle Scholar
  3. 3.
    Lowy AM. 2005, Does size matter most? Reassessing clinical staging for pancreatic cancer. Ann Surg Oncol 12:100–101.CrossRefPubMedGoogle Scholar
  4. 4.
    Lowy AM. 2004, From bad to worse: prognostic factors in pancreatic cancer. Ann Surg Oncol 11:117–118.CrossRefPubMedGoogle Scholar
  5. 5.
    Lowy AM. 2006, Putting the chemo in chemoradiation for pancreatic cancer. Ann Surg Oncol 13:135–136.CrossRefPubMedGoogle Scholar
  6. 6.
    Stojadinovic A, Hoos A, Brennan MF, 2002, Randomized clinical trials in pancreatic cancer. Surg Oncol Clin North Am 11:207–229.CrossRefGoogle Scholar
  7. 7.
    Alexakis N, Halloran C, Raraty M, 2004, Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427.CrossRefPubMedGoogle Scholar
  8. 8.
    Tseng JF, Raut CP, Lee JE, 2004, Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8: 935–949, discussion 949-950.CrossRefPubMedGoogle Scholar
  9. 9.
    McClusky DA 3rdSkandalakis LJ, Colborn GL, 2002, Harbinger or hermit. Pancreatic anatomy and surgery through the ages—part 2. World J Surg 26: 1370–1381.CrossRefPubMedGoogle Scholar
  10. 10.
    Whipple AO. 1949, An evaluation of radical surgery for carcinoma of the pancreas and ampullary region. Ann Intern Med 31: 624–627.PubMedGoogle Scholar
  11. 11.
    Ahmad SA, Lowy AM, McIntyre BC, 2005, Pancreaticoduodenectomy. J Gastrointest Surg 9:138–143.CrossRefPubMedGoogle Scholar
  12. 12.
    Kalser MH, Barkin J, MacIntyre JM. 1985, Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer 56:397–402.Google Scholar
  13. 13.
    Warshaw AL, Rattner DW, Fernandez-del Castillo C, 1998, Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue. Arch Surg 133:327–331.CrossRefPubMedGoogle Scholar
  14. 14.
    Kozarek R, Hovde O, Attia F, 2003, Do pancreatic duct stents cause or prevent pancreatic sepsis? Gastrointest Endosc 58:505–509.CrossRefPubMedGoogle Scholar
  15. 15.
    Sewnath ME, Birjmohun RS, Rauws EA, 2001, The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J Am Coll Surg 192:726–734.CrossRefPubMedGoogle Scholar
  16. 16.
    Sewnath ME, Karsten TM, Prins MH, 2002, A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236:17–27.CrossRefPubMedGoogle Scholar
  17. 17.
    Povoski SP, Karpeh MS Jr Conlon KC, 1999, Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230: 131–142.CrossRefPubMedGoogle Scholar
  18. 18.
    Sohn TA, Yeo CJ, Cameron JL, 2000, Do preoperative biliary stents increase postpancreati-coduodenectomy complications? J Gastrointest Surg 4:258–267, discussion 267-268.CrossRefPubMedGoogle Scholar
  19. 19.
    Pisters PW, Hudec WA, Hess KR, 2001, Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234:47–55.CrossRefPubMedGoogle Scholar
  20. 20.
    Maire F, Hammel P, Ponsot P, 2006, Long-term outcome of biliary and duodenal stents in pal-liative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 101:735–742.CrossRefPubMedGoogle Scholar
  21. 21.
    Mullen JT, Lee JH, Gomez HF, 2005, Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9:1094–1104, discussion 1104-1105.CrossRefPubMedGoogle Scholar
  22. 22.
    McClusky DA, 3rd Skandalakis LJ, Colborn GL, 2002, Harbinger or hermit. Pancreatic anatomy and surgery through the ages—part 3. World J Surg 26: 1512–1524.CrossRefPubMedGoogle Scholar
  23. 23.
    Traverso LW, Longmire WP Jr, 1978, Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146:959–962.PubMedGoogle Scholar
  24. 24.
    Traverso LW, Longmire WP Jr. 1980, Preservation of the pylorus in pancreaticoduodenectomy: a follow-up evaluation. Ann Surg 192: 306–310.CrossRefPubMedGoogle Scholar
  25. 25.
    Lin PW, Lin YJ. 1999, Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86:603–607.CrossRefPubMedGoogle Scholar
  26. 26.
    Seiler CA, Wagner M, Sadowski C, 2000, Randomized prospective trial of pylorus-preserving versus Classic duodenopancreatectomy (Whipple procedure ) : initial clinical results. J Gastrointest Surg 4:443–452.CrossRefPubMedGoogle Scholar
  27. 27.
    Zerbi A, Balzano G, Patuzzo R, 1995, Comparison between pylorus-preserving and Whipple pancreatoduodenectomy. Br J Surg 82:975–979.CrossRefPubMedGoogle Scholar
  28. 28.
    Tran KT, Smeenk HG, Eijck CH, van 2004, Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240:738–745.CrossRefPubMedGoogle Scholar
  29. 29.
    Tani M, Terasawa H, Kawai M, 2006, Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg 243:316–320.CrossRefPubMedGoogle Scholar
  30. 30.
    Pedrazzoli S, DiCarlo V, Dionigi R, 1998, Standard versus extended lymphadenectomy asso-ciated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517.Google Scholar
  31. 31.
    Yeo CJ, Cameron JL, Sohn TA, 1999, Pancreaticoduodenectomy with or without extended retro-peritoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229: 613–622, discussion 622-624.CrossRefPubMedGoogle Scholar
  32. 32.
    Yeo CJ, Cameron JL, Lillemoe KD, 2002, Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarci-noma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366, discussion 366-368.CrossRefPubMedGoogle Scholar
  33. 33.
    Yang YM, Wan YL, Tian XD, 2005, Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas. Chin Med J (Engl) 118:1863–1869.Google Scholar
  34. 34.
    Pawlik TM, Abdalla EK, Barnett CC, 2005, Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140: 584–589, discussion 589-591.CrossRefPubMedGoogle Scholar
  35. 35.
    Hough TJ, Raptopoulos V, Siewert B, 1999, Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 173: 1509–1512.PubMedGoogle Scholar
  36. 36.
    Tyler DS, Evans DB. 1994, Reoperative pancreaticoduodenectomy. Ann Surg 219:211–221.CrossRefPubMedGoogle Scholar
  37. 37.
    Rault A, SaCunha A, Klopfenstein D, 2005, Pancreaticojejunal anastomosis is preferable to pancreaticogastrostomy after pancreaticoduodenectomy for long-term outcomes of pancreatic exocrine function. J Am Coll Surg 201: 239–244.CrossRefPubMedGoogle Scholar
  38. 38.
    Aranha GV, Hodul PJ, Creech S, 2003, Zero mortality after 152 consecutive pancreaticoduo-denectomies with pancreaticogastrostomy. J Am Coll Surg 197:223–231, discussion 231-232.CrossRefPubMedGoogle Scholar
  39. 39.
    Takano S, Ito Y, Watanabe Y, 2000, Pancreaticojejunostomy versus pancreaticogastrostomy in reconstruction following pancreaticoduodenectomy. Br J Surg 87:423–427.CrossRefPubMedGoogle Scholar
  40. 40.
    Takano S, Ito Y, Oishi H, 2000, A retrospective analysis of 88 patients with pancreaticogastrostomy after pancreaticoduodenectomy. Hepatogastroenterology 47:1454–1457.PubMedGoogle Scholar
  41. 41.
    Crist DW, Sitzmann JV, Cameron JL. 1987, Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 206:358–365.CrossRefPubMedGoogle Scholar
  42. 42.
    Kurosaki I, Hatakeyama K. 2004, Omental wrapping of skeletonized major vessels after pan-creaticoduodenectomy. Int Surg 89:90–94.PubMedGoogle Scholar
  43. 43.
    Muftuoglu MA, Saglam A. 2003, A novel reconstructive procedure after pancreaticoduo-denectomy: J-pouch dunking pancreaticojejunostomy. Hepatogastroenterology 50:2233–2235.PubMedGoogle Scholar
  44. 44.
    Ohwada S, Tanahashi Y, Ogawa T, 2002, I n situ vs ex situ pancreatic duct stents of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy with billroth I-type reconstruction. Arch Surg 137:1289–1293.CrossRefPubMedGoogle Scholar
  45. 45.
    Lillemoe KD, Cameron JL, Kim MP, 2004, Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg 8:766–774.CrossRefPubMedGoogle Scholar
  46. 46.
    Yang YM, Tian XD, Zhuang Y, 2005, Risk factors of pancreatic leakage after pancreaticoduo-denectomy. World J Gastroenterol 11: 2456–2461.PubMedGoogle Scholar
  47. 47.
    Buchler M, Friess H, Klempa I,  1 992, Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163: 125–130, discussion 130-131.CrossRefPubMedGoogle Scholar
  48. 48.
    Friess H, Beger HG, Sulkowski U, 1995, Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 82:1270–1273.CrossRefPubMedGoogle Scholar
  49. 49.
    Montorsi M, Zago M, Mosca F, 1995, Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117:26–31.CrossRefPubMedGoogle Scholar
  50. 50.
    Bassi C, Falconi M, Lombardi D, 1994, Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Italian Study Group. Digestion 55 Suppl 1: 41–47.Google Scholar
  51. 51.
    Presti ME, Burton FR, Niehoff ML, 1998, Effect of octreotide on stimulated insulin release from pancreatic tissue slices. Pancreas 16: 141–147.CrossRefPubMedGoogle Scholar
  52. 52.
    Hesse UJ, DeDecker C, Houtmeyers P, 2005, Prospectively randomized trial using periopera-tive low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg 29:1325–1328.CrossRefPubMedGoogle Scholar
  53. 53.
    Lowy AM, Lee JE, Pisters PW, 1997, Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226:632–641.CrossRefPubMedGoogle Scholar
  54. 54.
    Yeo CJ, Cameron JL, Lillemoe KD, 2000, Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a pro-spective randomized placebo-controlled trial. Ann Surg 232: 419–429.CrossRefPubMedGoogle Scholar
  55. 55.
    Yeo CJ. 1999, Does prophylactic octreotide benefit patients undergoing elective pancreatic resection? J Gastrointest Surg 3: 223–224.CrossRefPubMedGoogle Scholar
  56. 56.
    Sarr MG. 2003, The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial. J Am Coll Surg 196:556–564, discussion 564-565, author reply 565.CrossRefPubMedGoogle Scholar
  57. 57.
    Suc B, Msika S, Piccinini M, 2004, Octreotide in the prevention of intra-abdominal complica-tions following elective pancreatic resection: a prospective, multicenter randomized control-led trial. Arch Surg 139: 288–294, discussion 295.CrossRefPubMedGoogle Scholar
  58. 58.
    Profili S, Feo CF, Meloni GB, 2003, Combined biliary and duodenal stenting for palliation of pancreatic cancer. Scand J Gastroenterol 38: 1099–1102.CrossRefPubMedGoogle Scholar
  59. 59.
    Andtbacka RH, Evans DB, Pisters PW. 2004, Surgical and endoscopic palliation for pancreatic cancer. Minerva Chir 59:123–136.PubMedGoogle Scholar
  60. 60.
    Deziel DJ, Wilhelmi B, Staren ED, 1996, Surgical palliation for ductal adenocarcinoma of the pancreas. Am Surg 62:582–588.PubMedGoogle Scholar
  61. 61.
    Lillemoe KD, Cameron JL, Hardacre JM, 1999, Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230: 322–28, discussion 328-330.CrossRefPubMedGoogle Scholar
  62. 62.
    Neoptolemos JP, Stocken DD, Dunn JA, 2001, Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768.CrossRefPubMedGoogle Scholar
  63. 63.
    Sohn TA, Yeo CJ, Cameron JL, 2000, Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4: 567–579.CrossRefPubMedGoogle Scholar
  64. 64.
    Nishimura Y, Hosotani R, Shibamoto Y, 1997, External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 39: 39–49.PubMedGoogle Scholar
  65. 65.
    Yeo CJ, Cameron JL, Lillemoe KD, 1995, Pancreaticoduodenectomy for cancer of the head of the pancreas 201 patients. Ann Surg 221:721–731, discussion 731-733.CrossRefPubMedGoogle Scholar
  66. 66.
    Nitecki SS, Sarr MG, Colby TV, 1995, Long-term survival after resection for ductal adeno-carcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66.CrossRefPubMedGoogle Scholar
  67. 67.
    Willett CG, Lewandrowski K, Warshaw AL, 1993, Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217: 144–148.Google Scholar
  68. 68.
    Hochwald SN, Burke EC, Jarnagin WR, 1999, Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134:261–266.CrossRefPubMedGoogle Scholar
  69. 69.
    Heslin MJ, Brooks AD, Hochwald SN, 1998, A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg 133:149–154.CrossRefPubMedGoogle Scholar
  70. 70.
    Hodul P, Creech S, Pickleman J, 2003, The effect of preoperative biliary stenting on postop-erative complications after pancreaticoduodenectomy. Am J Surg 186:420–425.CrossRefPubMedGoogle Scholar
  71. 71.
    Capussotti L, Massucco P, Ribero D, 2003, Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138: 1316–1322.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Curtis J. Wray
    • 1
  • Syed A. Ahmad
    • 2
  1. 1.M. D. Anderson Cancer CenterThe University of TexasHoustonUSA
  2. 2.Barrett Cancer CenterUniversity of CincinnatiCincinnatiUSA

Personalised recommendations